companydata.dkcompanydata.dk

BACH BOLIGCENTER ApS: Financial statements 2020

CVR: 12024584

Source: annual report 2020, Danish Business Authority

01/05/2019 – 30/04/2020

BACH BOLIGCENTER ApS (CVR 12024584) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -13,806 and a net result of DKK -165,894 compared with DKK 11,774 the year before. Equity in the 2020 report amounted to DKK 956,283. The solvency ratio was 98.6%.

Gross Profit
DKK -13,806
Profit/Loss
DKK -165,894
Equity
DKK 956,283
Total Assets
DKK 969,622
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020--14K-166K956K0
2019--17K12K1.2M1
2018--18K9K1.2M-
2017--13K78K1.3M-
2016--13K-48K1.2M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is BACH BOLIGCENTER ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

About BACH BOLIGCENTER ApS

BACH BOLIGCENTER ApS is a Danish company of the type Anpartsselskab based in Hammel, founded in 1988. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named EMBRYODAN ApS. The management consists of Geo Koch. The company is owned by Geo Koch. The company has 1 employee (2023). In 2026, the company reported a gross profit of DKK -12,635 and a net result of DKK 3,958 compared with DKK -35,885 the year before. Equity in the 2026 report amounted to DKK 243,122.

Source: annual report 2026, Danish Business Authority